UCB sells assets in emerging markets to GSK for €515 million

In a further streamlining move, UCB SA of Belgium said it has agreed to sell some 50 of its businesses and affiliates in the Far East, Middle East, Latin America and Africa to GlaxoSmithKline PLC of Britain for €515 million in cash.